Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceutical IncfiledCriticalRegeneron Pharmaceutical Inc
Publication of HN2009000575ApublicationCriticalpatent/HN2009000575A/en
ESTA INVENCION SE REFIERE A UN ANTICUERPO HUMANO AISLADO O UNO DE SUS FRAGMENTOS QUE SE UNE AL RECEPTOR ALFA DE ENTERLEUQINA-4 HUMANA (hIL-4a) CON UNA CONSTANTE DE AFINIDAD (Kd) DE MENOS DE 200 PM, SEGUN SE MIDE POR RESONANCIA DE PLASMON SUPERFICIAL.THIS INVENTION REFERS TO AN ISOLATED HUMAN ANTIBODY OR ONE OF ITS FRAGMENTS THAT JOINS THE HUMAN ENTERLEUQINA-4 ALPHAN RECEIVER (hIL-4a) WITH A CONSTANT OF AFFINITY (Kd) OF LESS THAN 200 PM, AS IS MEASURED BY RESONANCE OF SURFACE PLASMON.
HN2009000575A2006-08-242009-04-01
HIGH AFFINITY HUMAN ANTIBODIES FOR THE HUMAN IL-4 RECEIVER
HN2009000575A
(en)
METHOD FOR PRODUCING RECOMBINANT ENZYMATIC-LABELED HANTAVIRUS G2 ANTIGEN IN E.COLI CELLS FOR THE PURPOSE OF ITS APPLICATION IN AN IMMUNO-ENZYMAL ANALYSIS FOR DIAGNOSIS OF HFRS